Trichloroethane

Trichloroethane

SCHEMBL4603454

CC(Cl)(Cl)Cl.ClC(Cl)(Cl)Cl

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.86
ALDH1A1 P00352 2/20 0.57
LMNA P02545 1/20 0.57
CYP2E1 P05181 1/20 0.57
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trichloroethane SCHEMBL7072287 0.94 TSHR (0.75) TSHRALDH1A1LMNACYP2E1THRB
Trichloroethane SCHEMBL64609 0.93
Trichloroethane SCHEMBL3833855 0.93 TSHR (1.00) TSHRALDH1A1LMNACYP2E1THRB
Trichloroethane SCHEMBL10482068 0.93 TSHR (1.00) TSHRALDH1A1LMNACYP2E1THRB
Trichloroethane SCHEMBL16434 0.93
Trichloroethane SCHEMBL25372481 0.86
Trichloroethane SCHEMBL8720047 0.86
Trichloroethane SCHEMBL4605092 0.86
Trichloroethane SCHEMBL11347390 0.86
Trichloroethane SCHEMBL9279232 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1574505-B1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL CO (JP) 2008-07-16 EP disclosed
US-7361675-B2 1,2,4-thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2008-04-22 US disclosed
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-07-27 US disclosed
EP-1574505-A1 1,2,4-THIADIAZOLE COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-09-14 EP disclosed
EP-0430628-B1 Fluorine-containing copolymer composition MITSUI PETROCHEMICAL IND (JP) 1995-06-21 EP disclosed
US-5106895-A Organosilicon compound as monomer; curable MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1992-04-21 US disclosed
EP-0430628-A1 Fluorine-containing copolymer composition MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-06-05 EP disclosed
US-4341842-A Method of coating automotive parts with silicone compositions GENERAL ELECTRIC COMPANY (US) 1982-07-27 US disclosed
US-4233452-A TREATMENT AND PREVENTION OF CALCIUM OXALATE UROLITHIASIS MERCK & CO., INC. (US) 1980-11-11 US disclosed
US-4207329-A Derivatives of glycolic and glyoxylic acid as inhibitors of glycolic acid oxidase MERCK & CO., INC. (US) 1980-06-10 US disclosed
US-4037466-A Method of regenerating a glycol-ether type inspection penetrant remover by solvent extraction ALBURGER JAMES R 1977-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167266-A1 1,2,4- thiadiazole compounds and use thereof CBR3, CBR1, NOX3 TSHR 95/4885ALDH1A1 518/4885LMNA 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.